Community Health Systems, Inc. (NYSE:CYH) Receives $3.28 Consensus PT from Analysts

Community Health Systems, Inc. (NYSE:CYH) has earned a consensus recommendation of “Reduce” from the eight brokerages that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $3.2833.

A number of research analysts have issued reports on the company. Barclays decreased their target price on Community Health Systems from $3.50 to $3.00 and set an “equal weight” rating for the company in a research note on Thursday, April 23rd. Wall Street Zen cut Community Health Systems from a “hold” rating to a “sell” rating in a research note on Saturday, April 25th. Truist Financial decreased their target price on Community Health Systems from $3.50 to $3.00 and set a “hold” rating for the company in a research note on Thursday, April 23rd. Weiss Ratings cut Community Health Systems from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday, April 24th. Finally, Zacks Research cut Community Health Systems from a “strong-buy” rating to a “hold” rating in a research note on Friday, April 24th.

Community Health Systems Stock Up 0.2%

Shares of Community Health Systems stock opened at $2.81 on Friday. Community Health Systems has a 12 month low of $2.38 and a 12 month high of $4.43. The business has a fifty day simple moving average of $2.98 and a 200 day simple moving average of $3.22. The stock has a market cap of $395.28 million, a PE ratio of 0.82 and a beta of 1.89.

Community Health Systems (NYSE:CYH) last announced its quarterly earnings data on Tuesday, April 21st. The company reported ($0.48) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.30). Community Health Systems had a negative return on equity of 7.62% and a net margin of 3.78%.The company had revenue of $2.97 billion for the quarter, compared to analyst estimates of $2.89 billion. During the same period last year, the firm earned ($0.03) earnings per share. The firm’s revenue for the quarter was down 6.1% on a year-over-year basis. Community Health Systems has set its FY 2026 guidance at -0.600-0.000 EPS. Analysts expect that Community Health Systems will post -0.58 EPS for the current fiscal year.

Institutional Trading of Community Health Systems

Institutional investors have recently modified their holdings of the company. Royal Bank of Canada lifted its holdings in shares of Community Health Systems by 601.9% in the fourth quarter. Royal Bank of Canada now owns 9,286 shares of the company’s stock valued at $29,000 after purchasing an additional 7,963 shares in the last quarter. Wealth Enhancement Advisory Services LLC acquired a new stake in shares of Community Health Systems in the third quarter valued at approximately $32,000. Lazard Asset Management LLC acquired a new stake in shares of Community Health Systems in the fourth quarter valued at approximately $34,000. Wealthcare Advisory Partners LLC acquired a new stake in shares of Community Health Systems in the fourth quarter valued at approximately $35,000. Finally, Quarry LP bought a new position in Community Health Systems in the third quarter valued at $39,000. 84.99% of the stock is currently owned by institutional investors.

About Community Health Systems

Community Health Systems, Inc (NYSE: CYH) is one of the largest publicly traded hospital operators in the United States. Headquartered in Franklin, Tennessee, the company owns, leases and manages general acute care hospitals and outpatient facilities, primarily in non-urban and mid-market communities. CHS is focused on delivering locally accessible healthcare services through its network of affiliated hospitals, clinics and post-acute providers.

The company’s core offerings include inpatient medical and surgical care, emergency services, critical care, diagnostic imaging and laboratory testing.